Genetics

Decoding the complexity of Alzheimer's disease

Alzheimer's disease affects more than 6 million people in the United States, and there are very few FDA-approved treatments that can slow the progression of the disease.

Neuroscience

New blood marker can identify Parkinsonian diseases

In a study by researchers at Lund University the marker DOPA decarboxylase (DCC) was found to be elevated in individuals with Parkinson's disease as well as in people with other diseases that result in dopamine deficiency ...

page 11 from 40